Conflu3nce

Conflu3nce Overview

Conflu3nce applies its patented methods to the early detection of cognitive health changes in people across the cognitive spectrum. The company is developing PICSSi, a minimally-disruptive, on-demand system that addresses cognitive-motor issues for people across a wide range of ages and conditions, including Alzheimers disease, traumatic brain injury, Parkinsons disease, stroke, and attention-deficit/hyperactivity disorder. The systems multi-modal, multi-domain-based personalized interactive units are designed to cooperatively engage global cognition and can be delivered as hands-on or virtual/view-only experiences. The company's PICSSi and Stitch and Peel (SnP) technology is based on processes and methods that use content-rich, dynamic, 3D-like figure-ground image sets with image properties that can be manipulated and predicted. For early detection, PICSSi can be personalized to capture an individuals cognitive expression pattern without bias toward disease/symptom trajectories or domain-specific deficits. User-specific baselines are used to detect changes in cognition over time. And for training/remediation, users are guided through increasingly challenging interactions to develop and retrain their skills, processes, and processing based on their dynamic progress.

Cumulative Funding Raised Over Time ($)

Latest News

No news articles.

Funding

Team Members

4

Employees: 1-10

Web & Social Links

Locations

Emek Refa'im Street 30, P.O.Box 8514, Jerusalem 9108401, Israel

1181 South Parker Road, Suite 102, Denver, CO, USA

Photos & Videos

3 item(s)

Conflu3nce Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info